Veterinary Medicines

RISPOVAL 3 BRSV PI3 BVD LYOPHILISATE AND SUSPENSION FOR SUSPENSION FOR INJECTION FOR CATTLE

Authorised
  • Bovine parainfluenza virus 3, strain RLB103, Live
  • Bovine viral diarrhoea virus 1, strain 5960, Inactivated
  • Bovine viral diarrhoea virus 1, strain 6309, Inactivated
  • Bovine respiratory syncytial virus, strain 375, Live
Download as PDF

Product identification

Medicine name:
RISPOVAL 3 BRSV PI3 BVD LYOPHILISATE AND SUSPENSION FOR SUSPENSION FOR INJECTION FOR CATTLE
RISPOVAL 3 RS PI3 BVD LYOPHILISAT ET SUSPENSION POUR SUSPENSION INJECTABLE POUR BOVINS
Active substance:
  • Bovine parainfluenza virus 3, strain RLB103, Live
  • Bovine viral diarrhoea virus 1, strain 5960, Inactivated
  • Bovine viral diarrhoea virus 1, strain 6309, Inactivated
  • Bovine respiratory syncytial virus, strain 375, Live
Target species:
  • Cattle
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Bovine parainfluenza virus 3, strain RLB103, Live
    100000.00
    cell culture infective dose 50
    /
    1.00
    unit(s)
  • Bovine viral diarrhoea virus 1, strain 5960, Inactivated
    3.00
    log2 serum neutralising unit(s)
    /
    1.00
    unit(s)
  • Bovine viral diarrhoea virus 1, strain 6309, Inactivated
    3.00
    log2 serum neutralising unit(s)
    /
    1.00
    unit(s)
  • Bovine respiratory syncytial virus, strain 375, Live
    100000.00
    cell culture infective dose 50
    /
    1.00
    unit(s)
Pharmaceutical form:
  • Lyophilisate and suspension for suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AH
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - New active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/1611855 9/2003
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0146/001
Concerned member states:
  • Belgium
  • Bulgaria
  • Czechia
  • Estonia
  • Germany
  • Hungary
  • Ireland
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 22/05/2024
Download

Combined File of all Documents

English (PDF)
Published on: 24/01/2024
Download

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 22/05/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."